As ACT announced this CC about 10 days ago I am expecting we will hear on 10K(no debt, cash on hand for trials and operating costs etc) and expound as much as possible on clinical trials.( ongoing process with trial site IRB's, contracts signed soon type thing) Most likely touch on many things that can be viewed in last conference presentation(patents, Myoblast Phase 2, EU Orphan status, etc) If there is something new and exciting, I for one will welcome it. I don't expect bad news given the fact they announced this CC prior and we have seen the 10K plus timing the CC prior to opening bell. Nothing wrong with CC's and I for one hope they continue the practive for all of the investment community. For those who are unaware, the last conference call transcript can be read at the following link.(a group of shareholders pressured for this CC) http://www.sec.gov/Archives/edgar/data/1140098/000101376209001648/form14a.htm